Verastem Oncology

Verastem Oncology is a biopharmaceutical company dedicated to developing novel cancer therapies that address areas of high unmet need in RAS pathway-driven cancers. They are driven by a commitment to ensuring no cancer patient runs out of options, and their research focuses on the RAS pathway, which is implicated in nearly 30% of all human cancers. Verastem Oncology's lead investigational program is focused on low-grade serous ovarian cancer (LGSOC), and they are also exploring treatments for KRAS mutant non-small lung cancer (NSCLC) and other RAS-Pathway driven cancers.

Verastem Oncology is committed to collaborative partnerships, both within their organization and with external research and patient advocacy communities. They believe in the power of diverse experiences, perspectives, skills, and backgrounds to drive their pursuit of innovative treatments. They prioritize a culture of purposefulness, unwavering dedication, influence, insight, and symbiosis, all working together to bring hope to cancer patients.

Verastem Oncology offers a hybrid work environment, allowing employees to balance in-office and remote work arrangements. Their commitment to work-life balance is evident in their generous benefits package, which includes wellness programs and retirement savings options. While specific details regarding remote work arrangements for individual roles are not provided, the company's emphasis on employee well-being suggests a flexible and accommodating approach to work arrangements.

Verastem Oncology offers a comprehensive and competitive benefits package designed to support employees both in the present and the future. This package includes competitive pay programs with salary, bonus, and equity, as well as wellness programs, retirement savings, and generous work-life balance opportunities. The company strives to ensure its benefits are first-rate within the industry, comprehensive in coverage, cost-effective for employees, and supportive in staying healthy, planning for the future, and developing a career.

Verastem Oncology is a biopharmaceutical company focused on developing novel cancer therapies for patients with RAS pathway-driven cancers, which are often highly aggressive and difficult to treat. The company's mission is to ensure that no cancer patient runs out of options by pursuing unexplored pathways and developing treatments that address areas of high unmet need. Verastem Oncology emphasizes collaboration and teamwork, fostering a culture of purposefulness, unwavering dedication, influence, insight, and synergy to bring hope to patients and change the way cancer is treated.

Verastem Oncology fosters a collaborative and purpose-driven culture. The company values diversity, expertise, and different perspectives in its pursuit of developing innovative cancer therapies. They emphasize a team-oriented approach, encouraging open communication and challenges to the status quo, all in the pursuit of ensuring that no cancer patient runs out of options. Verastem's culture prioritizes influence, insight, and a symbiotic environment where team members and partners work together to achieve a common goal.

Verastem Oncology embraces diversity, equity, and inclusion as core principles of its culture. The company recognizes the value of diverse experiences, perspectives, and backgrounds in its pursuit of developing innovative cancer therapies. They are committed to creating an inclusive workplace where all team members feel valued, respected, and empowered to contribute their unique talents and ideas. This dedication to fostering a diverse and inclusive environment extends beyond internal operations, as Verastem prioritizes partnerships with patient advocacy groups and research communities to ensure that they represent a wide range of voices and perspectives in their efforts to improve cancer treatment.